Jason Higgins, MD
Orthopaedic Surgery · Thibodaux, LANPI 1891887022
Payments from drug & device makers
Across 141 payments — averaging $52.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Arthrex$2K
- ALON Medical Technology$1K
- Zimmer Biomet$371
- Amgen$211
- Pacira Pharmaceuticals Incorporated$201
- plus $775 from 14 others
What the payments were for
- Travel & lodging$3,58149%
- Food & beverage$3,68150%
- Education$210%
- Other$941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 35 | $2,663 |
| Arthrex | 22 | $2,051 |
| ALON Medical Technology | 13 | $1,106 |
| Zimmer Biomet | 3 | $371 |
| Amgen(2 entities) | 14 | $211 |
| Pacira Pharmaceuticals Incorporated | 12 | $201 |
| Pacira Therapeutics, Inc. | 8 | $147 |
| Ferring Pharmaceuticals Inc. | 10 | $139 |
| Zimvie Inc. | 1 | $94 |
| Bioventus LLC | 2 | $60 |
| Vericel Corporation | 3 | $57 |
| AbbVie | 4 | $56 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Johnson & Johnson | 1 | $43 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Endo Pharmaceuticals Inc. | 2 | $25 |
| Kerecis Limited | 2 | $22 |
| Advanced Oxygen Therapy Inc. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $12 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,438
- REUNION$150
- TRIATHLON$146
- Persona$143
- ROSA-Knee$143
- Fuzion$143
- Comp Reverse Shoulder E$118
- Robotics-Knees$110
How this compares
$7,378 in reported general payments places this provider in the 65th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 138 | $2,314 |
| Methylprednisolone | 27 | $164 |
| Cyclobenzaprine Hcl | 11 | $96 |
| Gabapentin | 19 | $91 |
| Meloxicam | 40 | $50 |
| Clindamycin Hcl | 15 | $21 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Thibodaux
- Neil MakiThibodaux$620K
- Pierce NunleyShreveport$3.8M
- Christopher HarrodBaton Rouge$3.1M
- Vinod DasaKenner$1.9M
- Jorge IsazaBaton Rouge$1.2M
- Robert ZuraNew Orleans$792K
- Kevin McCarthyBaton Rouge$714K
- Fernando SanchezNew Orleans$655K
- Timmothy RandellAlexandria$498K
- Robert EastonBaton Rouge$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.